HealthEquity (HQY) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
13 May, 2026Voting matters and shareholder proposals
Election of ten directors to serve until the 2027 annual meeting and until successors are elected and qualified.
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending January 31, 2027.
Advisory vote to approve fiscal 2026 compensation for named executive officers.
Approval of the 2026 Employee Stock Purchase Plan.
Approval of the Amended and Restated 2024 Equity Incentive Plan.
Board of directors and corporate governance
Ten nominees are recommended for election to the board, including Robert Selander, Scott Cutler, Stephen Neeleman, Adrian Dillon, Evelyn Dilsaver, William Gassen, Debra McCowan, Rajesh Natarajan, Stuart Parker, and Gayle Wellborn.
Executive compensation and say-on-pay
Advisory vote is being held to approve the compensation paid to named executive officers for fiscal 2026.
Proposals include approval of both an employee stock purchase plan and an amended equity incentive plan.
Latest events from HealthEquity
- Board recommends all proposals amid strong financials and enhanced governance and ESG oversight.HQY
Proxy filing13 May 2026 - Record HSA and revenue growth, margin expansion, and raised guidance signal strong momentum.HQY
Q4 202617 Mar 2026 - Q1 saw double-digit growth, record HSA assets, and upgraded full-year guidance after a major acquisition.HQY
Q1 202531 Jan 2026 - Revenue up 23%, net income up 239%, and $300M buyback announced for Q2 FY25.HQY
Q2 202522 Jan 2026 - CEO transition to Scott Cutler set for January 2025, with strong growth and innovation focus.HQY
Investor Update14 Jan 2026 - Digital innovation, AI, and margin expansion fuel strong HSA growth and robust financial outlook.HQY
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026 - Revenue up 21% with record HSA asset growth, strong guidance, and expanding market potential.HQY
Q3 202511 Jan 2026 - Record HSA growth, tech innovation, and legislative momentum fuel continued market leadership.HQY
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Record revenue and HSA growth drive strong FY25 results and positive FY26 outlook.HQY
Q4 202526 Dec 2025